Janel Corp. is a holding company, which engages in the provision of integrated logistics and freight forwarding services. It operates through the following business segments: Logistics, Life Sciences, and Manufacturing. The Logistics segment provides customs brokerage, warehousing, and distribution services and other value-added logistics services. The Life Sciences segment produces and sells monoclonal and polyclonal antibodies, diagnostic reagents, and other immunoreagents for biomedical research and provides antibody manufacturing for academic and industry research scientists. The Manufacturing segment manufactures and distributes mixing equipment, and apparatus for specific applications within various industries. The company was founded by James N. Jannello in 1974 and is headquartered in New York, NY.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company